![]() |
市场调查报告书
商品编码
1934308
碘市场-全球产业规模、份额、趋势、机会及预测(依来源、形态、应用、区域及竞争格局划分,2021-2031年)Iodine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast Segmented By Source, By Form, By Application, By Region & Competition, 2021-2031F |
||||||
全球碘市场预计将从 2025 年的 35.8 亿美元成长到 2031 年的 53.1 亿美元,复合年增长率为 6.79%。
碘是一种重要的非金属卤素,在工业、医药和农业等众多领域都发挥着不可或缺的作用。其需求成长主要得益于医疗诊断中造影剂需求的激增以及甲状腺药物和带碘化合物的持续需求。此外,在农业领域,为防止牲畜营养缺乏,强制在饲料中添加碘,确保了碘需求的稳定基础,使其不易受到市场短期波动的影响。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 35.8亿美元 |
| 市场规模:2031年 | 53.1亿美元 |
| 复合年增长率:2026-2031年 | 6.79% |
| 成长最快的细分市场 | 人类营养 |
| 最大的市场 | 北美洲 |
然而,由于生产地理集中,市场面临许多挑战,供应链极易受到供应中断和价格波动的影响。对有限供应来源的依赖造成了不确定性,并阻碍了买家的长期规划策略。美国地质调查局的数据显示,2024年前九个月晶体碘的平均现货价格徘徊在每公斤69美元左右,凸显了这些经济风险。这种波动性表明,金融市场的不稳定性可能会阻碍整体市场扩张。
推动全球碘市场成长的关键因素是全球对诊断影像中X光造影剂日益增长的需求。碘是这些药物中的关键造影剂,能够显着提高电脑断层扫描(CT)和X射线检查中器官和血管结构的显影效果。随着全球医疗基础设施的扩展,为应对慢性疾病和老龄化社会,碘基造影剂的使用量正在显着增长。例如,通用电气医疗集团(GE Healthcare)于2025年2月发布的「2024财年第四季及全年财务表现报告」显示,其製药诊断部门的销售额成长了9%,这主要得益于美国等主要市场对造影剂的持续需求。
同时,碘及其衍生物市场也受惠于医药应用领域的不断拓展,例如甲状腺治疗和消毒剂。除诊断领域外,碘是调节甲状腺功能的关键活性成分,也是优碘消毒剂的重要原料,后者广泛应用于临床。儘管其他领域的需求有所波动,但碘及其衍生物的需求仍然强劲。 Iofina公司于2025年5月发布的「2024年全年财务业绩」充分体现了这一领域的强劲势头,数据显示碘及其衍生物的销售额增长了31%,达到1690万美元。此外,智利化学矿业公司(SQM)在其于2025年6月发布的「2024年年度报告」中宣布,碘及其衍生的收入达到约9.68亿美元,进一步印证了这些应用在全球消费中的重要地位。
全球碘市场面临的主要障碍之一是生产基地的高度地理集中,这导致供应链结构僵化且脆弱。全球市场对特定地区的过度依赖缺乏足够的多元化,难以应对政治变革、物流中断和营运瓶颈等区域性挑战。因此,下游产业面临原材料供应风险的增加,阻碍了长期资本投资,并使库存管理更加复杂。供应持续性的不确定性也使得成本敏感产业的製造商不愿意扩大碘的使用量或开发新产品。
这种集中式的生产环境助长了依赖性,并使整个产业面临严重的稳定性问题。根据美国地质调查局(USGS)2024年的数据,智利仍将是全球领先的碘生产国,截至2023年,其碘产量约占全球总产量的66%。这种不平衡的市场份额表明,全球供应平衡高度依赖单一国家的营运可靠性,迫使买家采取防御性筹资策略而非激进的成长策略。这最终限制了碘产品的广泛商业性应用,而这对于市场的显着扩张至关重要。
碘基钙钛矿太阳能电池技术的出现,正在传统工业和製药用途之外,创造出新的高价值应用。这些先进的光伏技术将碘掺入钙钛矿晶体结构中,与标准硅电池相比,实现了更高的能量转换效率和光吸收效率,从而催生了对高纯度碘的特殊需求。该技术正迅速从实验阶段迈向产业化,其效率的不断突破标誌着其已具备大规模生产的条件。例如,2024年12月,Qcells公司宣布其钙钛矿-硅串联太阳能电池的效率达到了创纪录的28.6%,这不仅证明了该技术的成熟,也鼓励了对碘基可可再生能源解决方案的广泛投资。
同时,该产业正朝着战略供应链多元化方向发展,利用非传统盐水资源来应对地理集中带来的风险。生产商正积极采用先进的回收技术,从油田废水和其他富含碘的盐水流中提取碘,从而建立不依赖智利原生蕴藏量的、具有韧性的替代供应基地。这项转变不仅增强了全球供应安全,也体现了工业产品差异化的循环经济概念。 Iofina plc 于 2025 年 10 月发布的《2025 年第三季企业趋势报告》印证了这项转变。该报告显示,该公司从其盐水生产设施中生产了 215.8 公吨结晶质碘化物,比去年同期增加了 32%。
The Global Iodine Market is projected to expand from USD 3.58 Billion in 2025 to USD 5.31 Billion by 2031, registering a CAGR of 6.79%. As a vital nonmetallic halogen, iodine is integral to numerous applications across industrial, medical, and agricultural landscapes, with growth primarily fueled by the surging need for contrast media in medical diagnostics and the continuous demand for thyroid treatments and iodophors. Additionally, the agricultural industry ensures stable consumption levels through the mandatory inclusion of iodine in animal feed to avert nutritional deficiencies in livestock, providing a steady baseline demand independent of fleeting market shifts.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 3.58 Billion |
| Market Size 2031 | USD 5.31 Billion |
| CAGR 2026-2031 | 6.79% |
| Fastest Growing Segment | Human Nutrition |
| Largest Market | North America |
However, the market contends with significant hurdles due to the intense geographical concentration of production, which exposes the supply chain to potential disruptions and price instability. This dependence on a limited number of sources creates uncertainty that hampers long-term planning strategies for purchasers. Highlighting these economic risks, data from the U.S. Geological Survey indicates that in 2024, the average spot price for iodine crystal hovered around 69 dollars per kilogram during the first nine months of the year, a fluctuation that underscores the financial volatility capable of obstructing broader market development.
Market Driver
The primary catalyst accelerating the Global Iodine Market is the escalating worldwide requirement for X-ray contrast media within diagnostic imaging. Iodine acts as the crucial opacifying element in these pharmaceuticals, drastically improving the visualization of organs and vascular structures during Computed Tomography (CT) and X-ray examinations. As healthcare infrastructures expand globally to manage chronic diseases and aging demographics, the uptake of iodine-based contrast agents has risen substantially; for instance, GE HealthCare's 'Fourth Quarter and Full Year 2024 Financial Results' from February 2025 reported a 9 percent growth in their Pharmaceutical Diagnostics segment, attributed largely to the enduring demand for imaging agents in major markets like the United States.
Concurrently, the market is bolstered by broadening pharmaceutical applications, specifically regarding thyroid therapies and antiseptic preparations. Beyond diagnostics, iodine remains a vital active component for regulating thyroid health and producing povidone-iodine disinfectants that are ubiquitous in clinical environments, ensuring resilient demand for iodine derivatives despite fluctuations in other sectors. This segment's strength is highlighted by Iofina plc's '2024 Full Year Results' released in May 2025, which showed a 31 percent increase in iodine derivative sales to 16.9 million dollars, while Sociedad Quimica y Minera de Chile (SQM) reported in their June 2025 'Annual Report 2024' that iodine and derivatives revenues hit approximately 968 million dollars, confirming the essential role of these applications in global consumption.
Market Challenge
A major obstacle impeding the Global Iodine Market is the dense geographical concentration of production, which results in a rigid and susceptible supply chain architecture. Because the global market relies heavily on a few specific regions, it lacks the diversification needed to buffer against localized issues such as political changes, logistical failures, or operational bottlenecks. As a result, downstream industries face heightened risks regarding material availability, which deters long-term capital investment and complicates inventory control, leading manufacturers in cost-conscious sectors to hesitate in expanding usage or developing new products when supply continuity remains uncertain.
This centralized production environment fosters a dependency that subjects the entire industry to serious stability concerns. According to the U.S. Geological Survey in 2024, Chile remained the dominant global producer, responsible for roughly 66 percent of the world's iodine output in 2023. Such a lopsided market share suggests that global supply equilibrium is heavily dependent on the operational reliability of a single nation, compelling buyers to adopt defensive procurement tactics rather than pursuing aggressive growth strategies, which ultimately restricts the broader commercial adoption necessary for substantial market expansion.
Market Trends
The emergence of Iodine-Based Perovskite Solar Cell technology is generating a new, high-value application avenue that surpasses traditional industrial and pharmaceutical uses. These advanced photovoltaics employ iodine-infused perovskite crystal structures to attain superior energy conversion and light absorption efficiencies relative to standard silicon cells, creating niche demand for high-purity iodine grades. This technology is swiftly moving from experimental concepts to industrial reality, marked by efficiency milestones that indicate readiness for large-scale manufacturing; for example, Qcells announced in December 2024 that they achieved a world record efficiency of 28.6 percent for a perovskite-silicon tandem solar cell, demonstrating technical maturity that invites wider investment in iodine-reliant renewable energy solutions.
At the same time, the industry is witnessing a trend toward the Strategic Diversification of Supply Chains through non-traditional brine sources to counteract the dangers of geographical centralization. Producers are increasingly deploying advanced recovery methods to extract iodine from oilfield produced water and other rich brine streams, creating resilient alternative supply centers independent of the dominant Chilean reserves. This evolution not only strengthens global supply security but also embraces circular economy concepts by utilizing industrial byproducts, a shift illustrated by Iofina plc's 'Q3 2025 Corporate Update' from October 2025, which reported the production of 215.8 metric tonnes of crystalline iodide from brine-based facilities, marking a 32 percent rise over the same period the prior year.
Report Scope
In this report, the Global Iodine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Iodine Market.
Global Iodine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: